Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2024)
Oruka Therapeutics (ORKA) posted quarterly Depreciation & Amortization (CF) of $43000.0 for Q1 2026, up 168.75% year-over-year from $16000.0 in Q1 2025, and up 53.57% quarter-over-quarter from $28000.0 in Q4 2025.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $43000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 168.75% year-over-year to $43000.0; the TTM figure through Mar 2026 stood at $110000.0 (up 214.29% YoY), while the FY2025 annual figure was $83000.0, up 207.41% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $43000.0, up from $28000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $43000.0 in Q1 2026, with the low at $3000.0 in Q4 2023.
- The 5-year median for Depreciation & Amortization (CF) is $5000.0 (2022), against an average of $11437.5.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) tumbled 40.0% in 2023, then soared 533.33% in 2025.
- Oruka Therapeutics' Depreciation & Amortization (CF) stood at $5000.0 in 2022, then sank by 40.0% to $3000.0 in 2023, then soared by 433.33% to $16000.0 in 2024, then jumped by 75.0% to $28000.0 in 2025, then soared by 53.57% to $43000.0 in 2026.
- Business Quant data shows ORKA's Depreciation & Amortization (CF) at $43000.0 in Q1 2026, $28000.0 in Q4 2025, and $20000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 5,000.00 |